Updates

Proactis - 11.2p forecast for next year drops PE to 9.2

September 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Proactis has acquired Esize, a Netherlands spend management software business for a maximum €14.2m in cash, loan notes and shares with a further €1m deferred. Esize’s solutions cover the full procurement cycle for indirect spend and provide Proactis with additional capabilities in the travel and expense management and contract labour markets. These are two markets that are adjacent to, and of an equivalent size to, Proactis’ core indirect product procurement proposition. For 2017, Esize reported revenue of €5.1m (+19% YOY) and €1.7m EBITDA (+14% YOY).At the same time, Proactis has reported that its own deal intake was strong with the attrition of large customers stemmed. 64 new names with a total ini ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Fulham Shore - Signs of a recovery

Eckoh

Proactis (June 2020)

Proactis (October 2019)

Proactis (March 2019)

Proactis (June 2018)

Proactis - Mouthwatering margins (March 2018)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X